Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hooge, J. P.
Right arrow Articles by Redekop, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hooge, J. P.
Right arrow Articles by Redekop, W. K.
NEUROLOGY 1992;42:1907
© 1992 American Academy of Neurology

Multiple sclerosis with very late onset

John P. Hooge, MD and W. K. Redekop, MPH

Division of Neurology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Multiple sclerosis (MS) can present clinically after age 59, but only rarely. In a large MS population (N = 2,019), 0.6% of patients had their first symptom at age 60 or older. Of this group, six had clinically definite MS, two had laboratory-supported definite MS, and four had clinically probable MS. The onset at this age was characteristically a slow deterioration of motor function. Most (10 of 12) of these very late-onset patients had a progressive course of disease from onset.

Address correspondence and reprint requests to Dr. John P. Hooge, #702–1160 Burrard Street, Vancouver, BC, Canada V6Z 2E8.

Received October 10, 1991. Accepted for publication in final form March 10, 1992.




This article has been cited by other articles:


Home page
NeurologyHome page
H. Tremlett and V. Devonshire
Is late-onset multiple sclerosis associated with a worse outcome?
Neurology, September 26, 2006; 67(6): 954 - 959.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. Teuscher, R. W. Doerge, P. D. Fillmore, and E. P. Blankenhorn
eae36, a Locus on Mouse Chromosome 4, Controls Susceptibility to Experimental Allergic Encephalomyelitis in Older Mice and Mice Immunized in the Winter
Genetics, February 1, 2006; 172(2): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. L. Simone, D. Carrara, C. Tortorella, M. Liguori, V. Lepore, F. Pellegrini, A. Bellacosa, A. Ceccarelli, I. Pavone, and P. Livrea
Course and prognosis in early-onset MS: Comparison with adult-onset forms
Neurology, December 24, 2002; 59(12): 1922 - 1928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.